Peripartum cardiomyopathy: Inflammatory markers as predictors of outcome in 100 prospectively studied patients

European Heart Journal

Volumn 27, Issue 4, 2006, Pages 441-446

  Sliwa, Karen ^a   Förster, Olaf ^a   Libhaber, Elena ^a   Fett, James D ^b   Sundstrom, Jay Bruce ^c   Hilfiker Kleiner, Denise ^d   Ansari, Aftab A ^c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b Hospital Albert Schweitzer   (Haïti)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

C reactive protein; Fas Apo 1; Inflammatory markers; Peripartum cardiomyopathy; Predictors of outcome

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FAS ANTIGEN;

ADULT; AFRICA; ARTICLE; BLOOD SAMPLING; CARDIOMYOPATHY; CAUSE OF DEATH; CLINICAL EXAMINATION; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; EVALUATION; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; ANTIGENS, CD95; ARRHYTHMIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HUMANS; LONGITUDINAL STUDIES; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SOUTH AFRICA; STROKE VOLUME; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 32144462962     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi481     Document Type: Article

References (28)

1. Pearson GD, Veille JC, Rahimtoola S, Hsia, Oakley CM, Hosenpud JD, Ansari A, Baughman KL. Peripartum cardiomyopathy: National Institutes of Health workshop recommendations and review. JAMA 2000;283:262-267.
2. Reimold S, Rutherford J. Peripartum cardiomyopathy. N Engl J Med 2000;344:1629-1630.
3. Lampert M, Lang RM. Peripartum cardiomyopathy. Am Heart J 1995;130:860-870.
4. Fett JD, Carraway RD, Dowell DL, King ME, Pierre R. Peripartum cardiomyopathy in Hospital Albert Schweitzer District of Haiti. Am J Obstet Gynecol 2002;186:105-110.
5. Seftel H, Susser M. Maternity and myocardial failure in African women. Br Heart J 1961;23:43-52.
6. Sliwa K, Skudicky D, Bergemann A, Candy G, Hopley M, Sareli P. The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. Eur J Heart Fail 2002;4:305-309.
7. Demakis JG, Rahimtoola SH, Sutton GC, Meadows WR, Szanto PB, Tobin JR, Gunnar RM. Natural course of peripartum cardiomyopathy. Circulation 1971;44:1053-1061.
8. Felker GM, Thompson R, Joshua MH, Hruban RH, Clementson DE, Howard DL, Baughman KN, Kaspar MD. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342:1077-1084.
9. Sato Y, Takatsu Y, Kataoka K, Yamada T, Taniguchi R, Sasayama S, Matsumori A. Serial circulating concentrations of C-reactive protein, interleukin-4, and IL-6 in patients with acute left heart decompensation. Clin Cardiol 1999;22:811-813.
10. Kanebo K, Kanada T, Yamauchi Y, Hasegawa A, Iwasaki T, Arai M, Suzuki T, Kobayashi I, Nagai R. C-reactive protein in dilated cardiomyopathy. Cardiology 1999;91:215-219.
11. Volanakis JE. Human C-reactive protein: expression, structure, and function. Immunol 2001;38:189-197.
12. Rauchhaus M, Clark AL, Doehner W, Davos C, Bolfer A, Sharma R, Coates AJ, Anker SD. The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol. 2003;42:1933-1940.
13. Hayakawa Y, Chandra M, Wenfeng M, Shirani J, Heller Brown J, Dorn GW II, Armstrong R, Kitsis R. Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in peripartum cardiomyopathy of Galpha(q) transgenic mice. Circulation 2003;108:1037-1042.
14. Podewski E, Hilfiker A, Hilfiker-Kleiner D, Kaminski K, Drexler H. Stat 3 protects female hearts from postpartum cardiomyopathy in the mouse: the potential role of prolactin. (Abstract 2178). European Society of Cardiology Meeting, Munich 2004.
15. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie F, Hajjar RJ, Schmidt U, Semigan MJ, Dec GW, Khan BA. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996;335:1182-1189.
16. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P. Apoptosis in the failing human heart. N Engl J Med 1997;336:1131-1141.
17. Reiber JHC. Quantitative analysis of left ventricular function from equilibrium gated blood scintigrams: an overview of computer methods. Eur J Nucl Med 1985;10:97-110.
18. Sahn DJ, DeMaria A, Kisslo J, Weyman A. The Committee on M-mode Standarization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083.
19. Hameed A, Elkayam U. Peripartum cardiomyopathy. In: Crawford M, DiMarco J, eds. Cardiology. 1st ed. London: Mosby; 2001. p513.1.
20. Horwich TB, Hamilton MA, Fonarow GC. Low serum cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail 2002;8:216-224.
21. Horwich T, MacLellan, Fonarow GC. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure. J Am Coll Cardiol 2004;43:642-648.
22. Rauchhaus M, Coats AJS, Anker SD. The endotoxin-lipoprotein hypothesis. Lancet 2000;346:930-933.
23. Albert M, Glynn R, Buring J, Ridker PM. C-reactive protein levels among women of various ethnic groups living in the United States (from the women health study). Am J Cardiol 2004;93:1238-1242.
24. Sliwa K, Forster O, Zhanje F, Kachope J. Outcome of subsequent pregnancy in patients with documented peripartum cardiomyopathy. Am J Cardiol 2004;93:1441-1443.
25. Belloc F, Jaloustre C, Dumain P, Lacombe F, Lenoble M, Boisseau MR. Effect of pentoxifylline on apoptosis of cultured cells. J Cardiovasc Pharmacol 1995;25(Suppl. 2):S71-S74.
26. Suresh R, Vig M, Bhatia S, Goodspeed E, John B, Kandpal U, Srivastava S, George A, Sen R, Bal V, Durdik J, Rath S. Pentoxifylline functions as an adjunct in vivo to enhance T cell immune response by inhibiting activation-induced death. J Immunol 2002;169:4262-4272.
27. Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsi T, Ohnishi M, Fujii M, Matsumoto T, Yamamoto T, Takayama T, Kinoshita M. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure. J Card Fail 2001;7:322-328.
28. Ansari AA, Fett JD, Carraway RE, Mayne AE, Onlamoon N, Sundstrom JB. Autoimmune mechanism as the basis for human peripartum cardiomyopathy. Clin Rev Allergy Immunol 2002;23:301-324.